Arya Mani MD, and colleagues have discovered a therapeutic target for the treatment of nonalcoholic fatty liver disease and liver insulin resistance in type 2
Arya Mani MD, and colleagues have discovered a therapeutic target for the treatment of nonalcoholic fatty liver disease and liver insulin resistance in type 2